GTAM
NVO

Global Trust Asset Management’s Novo Nordisk NVO Stock Holding History

Global Trust Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$616K Sell
16,775
-1,570
-9% -$74.4K 0.24% 72
2025
Q4 		$933K Sell
18,345
-2,978
-14% -$152K 0.37% 56
2025
Q3 		$1.18M Sell
21,323
-1,000
-4% -$58.5K 0.54% 43
2025
Q2 		$1.54M Sell
22,323
-2,973
-12% -$202K 0.82% 26
2025
Q1 		$1.76M Sell
25,296
-558
-2% -$46.1K 1.07% 20
2024
Q4 		$2.22M Sell
25,854
-700
-3% -$75.7K 0.84% 28
2024
Q3 		$3.16M Sell
26,554
-173
-0.6% -$23.1K 1.17% 16
2024
Q2 		$3.82M Hold
26,727
– – 1.54% 11
2024
Q1 		$3.43M Buy
26,727
+358
+1% +$42.6K 1.41% 14
2023
Q4 		$2.73M Buy
26,369
+300
+1% +$29.7K 1.2% 15
2023
Q3 		$2.37M Sell
26,069
-1
-0% -$88 1.13% 17
2023
Q2 		$2.11M Sell
26,070
-130
-0.5% -$10.6K 0.95% 22
2023
Q1 		$2.08M Buy
26,200
+70
+0.3% +$4.96K 0.99% 23
2022
Q4 		$1.77M Hold
26,130
– – 0.89% 28
2022
Q3 		$1.3M Sell
26,130
-426
-2% -$22.8K 0.68% 41
2022
Q2 		$1.48M Sell
26,556
-146
-0.5% -$8.1K 0.73% 40
2022
Q1 		$1.48M Sell
26,702
-150
-0.6% -$7.7K 0.62% 41
2021
Q4 		$1.5M Hold
26,852
– – 0.59% 42
2021
Q3 		$1.29M Hold
26,852
– – 0.58% 42
2021
Q2 		$1.13M Sell
26,852
-300
-1% -$11.6K 0.54% 46
2021
Q1 		$915K Sell
27,152
-570
-2% -$20.3K 0.5% 50
2020
Q4 		$968K Hold
27,722
– – 0.53% 44
2020
Q3 		$960K Hold
27,722
– – 0.61% 37
2020
Q2 		$908K Hold
27,722
– – 0.63% 36
2020
Q1 		$834K Sell
27,722
-500
-2% -$14.9K 0.65% 34
2019
Q4 		$817K Sell
28,222
-80
-0.3% -$2.21K 0.49% 56
2019
Q3 		$732K Sell
28,302
-1,450
-5% -$36.7K 0.49% 68
2019
Q2 		$759K Sell
29,752
-80
-0.3% -$1.98K 0.51% 62
2019
Q1 		$780K Sell
29,832
-180
-0.6% -$4.42K 0.58% 50
2018
Q4 		$691K Sell
30,012
-134
-0.4% -$2.98K 0.62% 47
2018
Q3 		$711K Sell
30,146
-1,000
-3% -$24.4K 0.49% 58
2018
Q2 		$718K Hold
31,146
– – 0.54% 54
2018
Q1 		$767K Hold
31,146
– – 0.6% 45
2017
Q4 		$836K Buy
+31,146
New +$792K 0.59% 46

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Global Trust Asset Management's NVO Position: Q1 2026 in Review

Global Trust Asset Management reduced its Novo Nordisk (NVO) stake by 8.6% in Q1 2026, selling an estimated $74.4K and leaving 16,775 shares worth $616K. The position accounts for 0.24% of the portfolio, ranked #72.

Global Trust Asset Management first reported a position in NVO in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.82M in Q2 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Global Trust Asset Management held 16,775 shares of Novo Nordisk worth $616K as of Q1 2026.
  • Global Trust Asset Management sold 1,570 Novo Nordisk shares in Q1 2026, an estimated $74.4K.
  • Novo Nordisk made up 0.24% of Global Trust Asset Management's portfolio in Q1 2026, its #72 holding.
  • Global Trust Asset Management first reported a position in Novo Nordisk in Q4 2017 and has held it in 34 quarters since.
  • Global Trust Asset Management's Novo Nordisk position peaked at $3.82M in Q2 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Global Trust Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.